Newsroom
Sorted by: Latest
-
United Arab Emirates Amines Market Business Report 2025: PESTEL Analysis, Producers and Product Range, Export and Import, Major Wholesalers and Trading Companies, Consumers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Amines Market in United Arab Emirates: Business Report 2025" report has been added to ResearchAndMarkets.com's offering. The report presents analysis of the amines market in United Arab Emirates. Scope Brief country profile includes general information and main economic indicators and specifies business environment in United Arab Emirates Amines market is analyzed by different parameters including domestic production and consumption. Future market development is al...
-
AM Best Affirms Credit Ratings of Colonnade Insurance S.A.
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-” (Excellent) of Colonnade Insurance S.A. (Colonnade) (Luxembourg), a member of the Fairfax Financial Holdings Limited (Fairfax) [TSX: FFH] group of companies. The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Colonnade’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance,...
-
TotalEnergies SE UK Regulatory Announcement: Director/PDMR Shareholding
PARIS--(BUSINESS WIRE)-- Notification and Public Disclosure of transactions by Persons Discharging Managerial Responsibilities Paris, January 9, 2026 – TotalEnergies SE has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the UK Market Abuse Regulation. About TotalEnergies TotalEnergies is a global integrated energy company that...
-
Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 1/8/2026 Issue ¦ HOLMES MASTER ISSUER PLC 2025-2 Series 1 Class A1 GBP 750,000,000 FRN Due in Oct 2072 ISIN Number ¦ XS3109480551 ISIN Reference ¦ 310948055 Issue Nomin GBP ¦ 750000000 Period ¦ 10/15/2025 to 1/15/2026 Payment Date 1/15/2026 Number of Days ¦ 92 Rate ¦ 4.4331 Denomination GBP ¦ 1000 ¦ 750000000 ¦ Amount Payable per Denomination ¦ 11.17 ¦ 8380380.82 ¦ Bank o...
-
KBRA Assigns AAA Rating to State of Maryland General Obligation Bonds
NEW YORK--(BUSINESS WIRE)--KBRA assigns a long-term rating of AAA with the Stable Outlook to the State of Maryland's General Obligation Bonds. The rating is underpinned by the State's established track record of conservative budget management; moderate debt and continuing obligations profile; and, a resource base that while slow growing, is characterized by strong educational attainment, structurally low unemployment, and per capita personal income exceeding the national average. The rating pla...
-
Polymarket Opens New Channels for Fan Engagement as the Exclusive Prediction Market Partner to the Golden Globes®
NEW YORK & LOS ANGELES--(BUSINESS WIRE)--Polymarket, the world’s largest prediction market, today announced a first-of-its-kind partnership with the Golden Globes®, becoming the exclusive prediction market partner of the annual awards show. The collaboration will bring real-time, market-driven insights across the Golden Globes live events and a broad digital and editorial ecosystem touching fans' greatest passion points across entertainment, fashion and pop culture. As part of the partnership,...
-
KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease
WASHINGTON--(BUSINESS WIRE)--KeifeRx, a privately held biotechnology company developing disease-modifying therapies for neurodegenerative disorders, today announced that it has entered into a research collaboration and option agreement with Amneal Pharmaceuticals to support the pre-IND development of KFRX06, KeifeRx’s preclinical candidate designed to inhibit leucine-rich repeat kinase 2 (LRRK2), a gene strongly implicated in Parkinson’s disease biology. Under the agreement, KeifeRx will conduc...
-
BCG and Hippocratic AI Announce Strategic Collaboration to Deploy Agentic AI Across Biopharma and Medtech
SAN FRANCISCO--(BUSINESS WIRE)--Combining Hippocratic AI’s safety-first technology and health care specialization with BCG’s strategic, operational, and AI transformation expertise...
-
United States Amines Market Business Report 2025: PESTEL Analysis, Producers and Product Range, Export and Import, Major Wholesalers and Trading Companies, Consumers - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Amines Market in United States: Business Report 2025" report has been added to ResearchAndMarkets.com's offering. The report presents analysis of the amines market in United States. Scope Brief country profile includes general information and main economic indicators and specifies business environment in United States Amines market is analyzed by different parameters including domestic production and consumption. Future market development is also estimated Trade an...
-
MCME Carell Completes Acquisition of City Office REIT
NEW YORK--(BUSINESS WIRE)--A joint venture between Elliott Investment Management L.P. (together with its affiliates, “Elliott”) and Morning Calm Management, LLC (collectively, “MCME Carell”) announced today that MCME Carell has completed its previously announced acquisition of City Office REIT, Inc. (NYSE: CIO) (“City Office REIT” or “CIO”) for $7.00 per share of common stock. As a result of the transaction, CIO’s common stock will no longer be listed on any public market. James Farrar, City Of...